Evidence of association of macrophage migration inhibitory factor gene polymorphisms with systemic lupus erythematosus
The aim of this study was to evaluate the potential association of functional polymorphisms of macrophage migration inhibitory factor with systemic lupus erythematosus. Our study includes 711 systemic lupus erythematosus (SLE) patients and 755 healthy controls. We genotyped the migration inhibitory...
- Autores:
- Tipo de recurso:
- Fecha de publicación:
- 2006
- Institución:
- Universidad del Rosario
- Repositorio:
- Repositorio EdocUR - U. Rosario
- Idioma:
- eng
- OAI Identifier:
- oai:repository.urosario.edu.co:10336/24139
- Acceso en línea:
- https://doi.org/10.1038/sj.gene.6364310
https://repository.urosario.edu.co/handle/10336/24139
- Palabra clave:
- Macrophage migration inhibition factor
Adult
Allele
Article
Clinical feature
Controlled study
Genetic association
Genetic polymorphism
Genetic susceptibility
Genotype
Haplotype
Human
Major clinical study
Pathogenesis
Polymerase chain reaction
Priority journal
Statistical significance
Systemic lupus erythematosus
Adult
Alleles
Case-control studies
Chromosome mapping
Confidence intervals
European continental ancestry group
Female
Gene frequency
Haplotypes
Humans
Macrophage migration-inhibitory factors
Male
Microsatellite repeats
Middle aged
Odds ratio
Promoter regions (genetics)
human
genetic
single nucleotide
systemic
pair 22
Chromosomes
Lupus erythematosus
Polymorphism
Polymorphism
- Rights
- License
- Abierto (Texto Completo)
Summary: | The aim of this study was to evaluate the potential association of functional polymorphisms of macrophage migration inhibitory factor with systemic lupus erythematosus. Our study includes 711 systemic lupus erythematosus (SLE) patients and 755 healthy controls. We genotyped the migration inhibitory factor (MIF) -173G/C using a polymerase chain reaction (PCR) system with predeveloped TaqMan allelic discrimination assay and the MIF -794 CATTn microsatellite polymorphism using a PCR-fluorescent method. A statistically significant difference in the distribution of the MIF -173*C allele between SLE patients and controls (P=0.004, OR=1.34, 95% CI=1.05-1.27) was observed. In addition, the frequency of the MIF -173* C/C genotype was higher in SLE patient (P=0.002, OR 2.58, 95% CI 1.32-5.10). No differences in the distribution of CATTn were found. However, the haplotypes analyses showed that only the CATT7-MIF -173* C haplotype was associated with a higher susceptibility to SLE (P=0.001, OR 1.84, 95% CI 1.35-2.79). No association with clinical features was detected in any case. These results suggest that both, MIF -173*C allele and CATT7-MIF -173*C haplotype, confer susceptibility to SLE in our population. © 2006 Nature Publishing Group. All rights reserved. |
---|